Customized research for RLMD vs. FPRX!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for RLMD vs. FPRX.


↗ Join Our Free Email Newsletter.




Relmada Therapeutics, Inc. vs. Five Prime Therapeutics, Inc.

Industry Match! Industry of Both RLMD and FPRX:

Health Care/Life Sciences

RLMD
Data Last Updated: More than 3 wks ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 264.657M


P/E: N/A

P/S: N/A

Q P/B: 34.78

Y Rev: -

Q Rev: -

Beta: -0.09

RLMD Share Stats

Outstanding Shares

33.26M

Float Shares

N/A

Percent of Float Short

N/A

RLMD Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

RLMD Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

RLMD in Pulse Portal

Stream of Posts

RLMD Symbol Page

Share RLMD Insights

Express Sentiment

'Buy' or 'Sell' RLMD

RLMD Profile

CEO

Dr. Sergio Traversa

Exchange

Nasdaq

Employees

4.00

About

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. It engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases and...

RLMD Financials

Annual Financials

Income Statement

Revenue

-

Net Income

(17.32M)

Cash Flow Statement

Change in Cash / Investments

6.98M

Balance Sheet

Cash / Investments

9.22M

Short Term Debt

364,204

Long Term Debt

None

Total Current Assets

9.98M

Total Current Liabilities

2.61M

Total Assets

10.22M

Total Liabilities

2.61M

Stockholder Equity

7.61M

Quarterly Financials

Income Statement

Q Revenue

-

Q Net Income

(4.12M)

Cash Flow Statement

Q Change in Cash / Investments

7.16M

Balance Sheet

Q Cash / Investments

9.22M

Q Short Term Debt

364,204

Q Long Term Debt

None

Q Total Current Assets

9.98M

Q Total Current Liabilities

2.61M

Q Total Assets

10.22M

Q Total Liabilities

2.61M

Q Stockholder Equity

7.61M

RLMD Charts

10-Year Chart

RLMD 10-Year Chart

5-Year Chart

RLMD 5-Year Chart

1-Year Chart

RLMD 1-Year Chart

6-Month Chart

RLMD 6-Month Chart

3-Month Chart

RLMD 3-Month Chart

1-Month Chart

RLMD 1-Month Chart

1-Day Chart

RLMD 1-Day Chart

FPRX
Data Last Updated: More than 2 wks ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 127.736M


P/E: N/A

P/S: 2.56

Q P/B: 0.72

Y Rev: 49.87M

Q Rev: 2.98M

Beta: 2.55

FPRX Share Stats

Outstanding Shares

36.05M

Float Shares

35.34M

Percent of Float Short

3.86%

FPRX Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

FPRX Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

FPRX in Pulse Portal

Stream of Posts

FPRX Symbol Page

Share FPRX Insights

Express Sentiment

'Buy' or 'Sell' FPRX

FPRX Profile

CEO

Mr. Bill R. Ringo

Exchange

Nasdaq

Employees

209.00

About

Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on discovering and developing novel protein therapeutics. product candidates includes, Cabiralizumab(FPA008), Bemarituzumab(FPA144), and FPA150. The FPA008 is an antibody that inhibits...

FPRX Financials

Annual Financials

Income Statement

Revenue

49.87M

Net Income

(140.45M)

Cash Flow Statement

Change in Cash / Investments

(15.84M)

Balance Sheet

Cash / Investments

270.14M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

288.57M

Total Current Liabilities

27.49M

Total Assets

321.53M

Total Liabilities

56.4M

Stockholder Equity

265.14M

Quarterly Financials

Income Statement

Q Revenue

2.98M

Q Net Income

(36.07M)

Cash Flow Statement

Q Change in Cash / Investments

10.63M

Balance Sheet

Q Cash / Investments

185.99M

Q Short Term Debt

3.94M

Q Long Term Debt

None

Q Total Current Assets

197.49M

Q Total Current Liabilities

28.51M

Q Total Assets

258.54M

Q Total Liabilities

80.11M

Q Stockholder Equity

178.43M

FPRX Charts

10-Year Chart

FPRX 10-Year Chart

5-Year Chart

FPRX 5-Year Chart

1-Year Chart

FPRX 1-Year Chart

6-Month Chart

FPRX 6-Month Chart

3-Month Chart

FPRX 3-Month Chart

1-Month Chart

FPRX 1-Month Chart

1-Day Chart

FPRX 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon